Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC
Authors
Keywords
-
Journal
Thoracic Cancer
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-11-25
DOI
10.1111/1759-7714.13248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical significance of cancer-associated fibroblasts and their correlation with microvessel and lymphatic vessel density in lung adenocarcinoma
- (2019) Ling Chen et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routine oncology practice in Germany
- (2019) Mark-Oliver Zahn et al. BMC CANCER
- Fibroblasts in cancer: Defining target structures for therapeutic intervention
- (2019) Maximilian Boesch et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- CD34 Differentially Regulates Contractile and Noncontractile Elements of Airway Reactivity
- (2018) Katherine Lortie et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer
- (2018) Jurgita Jackute et al. BMC IMMUNOLOGY
- Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis
- (2018) Jae-Gu Cho et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
- (2018) Thomas Karsten Kilvaer et al. PLoS One
- Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma
- (2018) Rei Atono Itou et al. HUMAN PATHOLOGY
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinicopathological study of role of CD34 expressions in the stroma of premalignant and malignant lesions of uterine cervix
- (2018) Mohsin Aijaz et al. Annals of Diagnostic Pathology
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema
- (2017) Margaret F. Doyle et al. PLoS One
- Basic Fibroblast Growth Factor Induces Angiogenic Properties of Fibrocytes to Stimulate Vascular Formation during Wound Healing
- (2016) Miho Nakamichi et al. AMERICAN JOURNAL OF PATHOLOGY
- Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study
- (2016) S. Kanda et al. ANNALS OF ONCOLOGY
- Conservation of immune gene signatures in solid tumors and prognostic implications
- (2016) Julia Chifman et al. BMC CANCER
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
- (2015) Lars Henning Schmidt et al. PLoS One
- US lung cancer trends by histologic type
- (2014) Denise Riedel Lewis et al. CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic relevance of cancer-associated fibroblasts in human cancer
- (2014) Janna Paulsson et al. SEMINARS IN CANCER BIOLOGY
- Functional subsets of mesenchymal cell types in the tumor microenvironment
- (2014) Eliane Cortez et al. SEMINARS IN CANCER BIOLOGY
- Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012
- (2013) Fred R. Hirsch et al. Journal of Thoracic Oncology
- Current data on predictive markers for anti-angiogenic therapy in thoracic tumours
- (2010) N. Reinmuth et al. EUROPEAN RESPIRATORY JOURNAL
- Staging of non-small cell lung cancer (NSCLC): A review
- (2010) S. Tsim et al. RESPIRATORY MEDICINE
- Immunohistochemical markers of proliferation and vascularisation in preneoplastic bronchial lesions and invasive non-small cell lung cancer
- (2009) I. CAVARGA et al. NEOPLASMA
- Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis
- (2008) Annika Andersson-Sjöland et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started